Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PACS Group, Inc. (PACS : NYSE)

• Company Description    PACS Group Inc. is a holding company investing in post-acute healthcare facilities, professionals and ancillary services. PACS Group Inc. is based in FARMINGTON, Utah. Number of Employees: 45,680

• Price / Volume Information    Yesterday's Closing Price: $41.18 Daily Weekly Monthly 20 Day Moving Average: 1,117,227 shares Shares Outstanding: 156.62 (millions) Market Capitalization: $6,449.41 (millions) Beta: -0.68 52 Week High: $42.62 52 Week Low: $7.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 32.33% 31.67% 12 Week 224.51% 212.79% Year To Date 7.27% 6.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 262 N. UNIVERSITY AVENUE - FARMINGTON,UT 84025 USA ph: 801-447-9829 fax: - ir@pacs.com http://www.pacs.com

• General Corporate Information    Officers Jason Murray - Chairman and Chief Executive Officer Mark Hancock - Executive Vice Chairman and Interim Chief Financia Joshua Jergensen - President and Chief Operating Officer Jacqueline Millard - Director Taylor Leavitt - Director Peer Information PACS Group, Inc. (CHCR) PACS Group, Inc. (ESRX) PACS Group, Inc. (MYDP) PACS Group, Inc. (COR) PACS Group, Inc. (GBCS) PACS Group, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 69380Q107 SIC: 8051 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 11/18/26 Share - Related Items Shares Outstanding: 156.62 Most Recent Split Date: (:1) Beta: -0.68 Market Capitalization: $6,449.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.43 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.05 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 15.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/18/26

• Fundamental Ratios P/E Current FY Estimate: 20.12 Trailing 12 Months: 39.22 PEG Ratio: 1.34 Price Ratios Price/Book: 7.35 Price/Cash Flow: 62.96 Price / Sales: 1.26 EPS Growth vs. Year Ago Period: 220.00% vs. Previous Quarter: 3.23% Sales Growth vs. Year Ago Period: 31.01% vs. Previous Quarter: 2.70% ROE 12/31/25 - - 09/30/25 - 21.39 06/30/25 - 17.92 ROA 12/31/25 - - 09/30/25 - 3.09 06/30/25 - 2.55 Current Ratio 12/31/25 - - 09/30/25 - 0.94 06/30/25 - 0.92 Quick Ratio 12/31/25 - - 09/30/25 - 0.94 06/30/25 - 0.92 Operating Margin 12/31/25 - - 09/30/25 - 3.29 06/30/25 - 2.74 Net Margin 12/31/25 - - 09/30/25 - 3.29 06/30/25 - 2.74 Pre-Tax Margin 12/31/25 - - 09/30/25 - 5.04 06/30/25 - 4.48 Book Value 12/31/25 - - 09/30/25 - 5.60 06/30/25 - 5.33 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.28 06/30/25 - 0.30 Debt-to-Capital 12/31/25 - - 09/30/25 - 21.90 06/30/25 - 23.31

Powered by Zacks Investment Research ©